000 | 01282 a2200337 4500 | ||
---|---|---|---|
005 | 20250515192147.0 | ||
264 | 0 | _c20100119 | |
008 | 201001s 0 0 eng d | ||
022 | _a1476-5381 | ||
024 | 7 |
_a10.1111/j.1476-5381.2009.00484.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStewart, A G | |
245 | 0 | 0 |
_aMediators and receptors in the resolution of inflammation: drug targeting opportunities. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cOct 2009 |
||
300 |
_a933-5 p. _bdigital |
||
500 | _aPublication Type: Editorial; Introductory Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnnexin A1 _ximmunology |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 |
_aFatty Acids, Omega-3 _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _ximmunology |
650 | 0 | 4 |
_aInflammation Mediators _xphysiology |
650 | 0 | 4 |
_aLipoxins _xphysiology |
650 | 0 | 4 |
_aReceptor, PAR-1 _ximmunology |
650 | 0 | 4 |
_aReceptors, Formyl Peptide _ximmunology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
773 | 0 |
_tBritish journal of pharmacology _gvol. 158 _gno. 4 _gp. 933-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1476-5381.2009.00484.x _zAvailable from publisher's website |
999 |
_c19237278 _d19237278 |